Vaxelis 0.5 ml, Injektionssuspension

7680669400026 CH-66940 Injektionssuspension

Associated product:

VAXELIS susp inj av 2 aiguilles 10 ser pré 0.5 ml
Vaxelis 0.5 ml, Injektionssuspension
Vaxelis 0.5 ml, Injektionssuspension
Vaxelis 0.5 ml, Injektionssuspension
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/06/2024
Summary of Product Characteristics
Français
17/06/2024
Summary of Product Characteristics
Italien
17/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
53.0 UG Substance Wirkstoff (Principe actif)
(N/A)
3.0 UG Substance WIIS
(N/A)
50.0 UG Substance WIIS
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
20.0 UG Substance Wirkstoff (Principe actif)
(N/A)
20.0 UG Substance Wirkstoff (Principe actif)
(N/A)
3.0 UG Substance Wirkstoff (Principe actif)
(N/A)
5.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
40.0 U Substance Wirkstoff (Principe actif)
(N/A)
8.0 U Substance Wirkstoff (Principe actif)
(N/A)
32.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.95 MG Substance HBESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
66940
Drug name
Vaxelis, Injektionssuspension
Galenic form
SUPA
ATC Code
J07CA09
Authorization status
Z
Dispensing category
B
First authorization
28/08/2019
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
Grundimmunisierung und Auffrischimpfung bei Säuglingen und Kleinkindern ab einem Alter von 6 Wochen bis 4 Jahre (vor dem 5. Geburtstag) gegen Diphtherie, Tetanus, Pertussis, Hepatitis B, Poliomyelitis und durch Haemophilus influenzae Typ b (Hib) verursachte invasive Krankheiten.

Package details

Description (FR)
VAXELIS susp inj av 2 aiguilles 10 ser pré 0.5 ml
Description (DE)
VAXELIS Inj Susp mit 2 Nadeln 10 Fertspr 0.5 ml
Market launch
28/08/2019
Narcotic (BTM)
No

Other package sizes (3)

VAXELIS susp inj av 2 aiguilles ser pré 0.5 ml
1 FESP
GTIN: 7680669400019
View
VAXELIS susp inj avec 1 aiguille 10 ser pré 0.5 ml
10 FESP
GTIN: 7680669400033
View
None
1 FESP
GTIN: None
Not in V1